Telix Pharmaceuticals Lim... (TLX)
NASDAQ: TLX
· Real-Time Price · USD
10.17
0.60 (6.27%)
At close: Oct 01, 2025, 3:59 PM
10.01
-1.57%
After-hours: Oct 01, 2025, 05:11 PM EDT
Telix Pharmaceuticals Revenue
Telix Pharmaceuticals reported an annual revenue of $783.21M, reflecting a 55.85% growth. For the quarter ending December 31, 2024, Telix Pharmaceuticals generated $594.24M in revenue.
Revenue (ttm)
783.21M
Revenue Growth
55.85%
Price / Sales Ratio
10.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.44B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 783.21M | +55.85% |
| Dec 31, 2023 | 502.55M | +213.90% |
| Dec 31, 2022 | 160.1M | +2007.64% |
| Dec 31, 2021 | 7.6M | +45.71% |
| Dec 31, 2020 | 5.21M | +49.58% |
| Dec 31, 2019 | 3.48M | +1685.88% |
| Dec 31, 2018 | 195.14K | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Sep 30, 2000 | 0 | n/a |
| Sep 30, 1999 | 0 | n/a |